Page last updated: 2024-09-04

ezetimibe and 4-(2-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid

ezetimibe has been researched along with 4-(2-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid in 1 studies

Compound Research Comparison

Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010)
(ezetimibe)
Studies
(4-(2-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid)
Trials
(4-(2-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid)
Recent Studies (post-2010) (4-(2-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid)
2,4845631,465828

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bloks, VW; Boesjes, M; Bos, T; Boverhof, R; de Boer, JF; Groen, AK; Jurdzinski, A; Kremoser, C; Kuipers, F; Kuivenhoven, JA; Moschetta, A; Oude Elferink, RPJ; Schonewille, M; van Deursen, JM; van Dijk, TH; Verkade, HJ; Wolters, H; Wolters, JC1

Other Studies

1 other study(ies) available for ezetimibe and 4-(2-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid

ArticleYear
Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.
    Gastroenterology, 2017, Volume: 152, Issue:5

    Topics: Animals; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 8; Benzoates; Bile Acids and Salts; Bile Ducts; Cholesterol; Ezetimibe; Fibroblast Growth Factors; Intestinal Elimination; Intestinal Mucosa; Intestines; Isoxazoles; Lipoproteins; Male; Mice; Mice, Knockout; Mice, Transgenic; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear

2017